Articles tagged with "PsA Resource Center"

Psoriatic Arthritis Drugs At a Glance, 2023

April 21, 2023 • By Mary Choy, PharmD, BCGP, FASHP

First Biosimilar to Adalimumab (Humira) Enters the U.S. Market After Years of Legal Battles

January 31, 2023 • By Michele B. Kaufman, PharmD, BCGP

Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

December 1, 2022 • By Walter P. Maksymowych, MB ChB, FACP, FRCP(C)

Challenges in Psoriatic Arthritis

November 29, 2022 • By Samantha C. Shapiro, MD

Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis

November 29, 2022 • By Ashley Krivohlavek

FDA Approves Ustekinumab for Children with PsA

November 7, 2022 • By Michele B. Kaufman, PharmD, BCGP

Psoriatic Arthritis & the Obese Patient

November 6, 2022 • By Linda Kossoff

Updates on PsA: Insights into the Latest Psoriatic Arthritis Treatments & Research

August 11, 2022 • By Jason Liebowitz, MD

Phase 2 Study Shows Promising Results for Deucravacitinib in PsA

July 19, 2022 • By Michele B. Kaufman, PharmD, BCGP

Spine School: Axial Manifestations of Psoriatic Arthritis

July 15, 2022 • By Jason Liebowitz, MD

1
2
3
…
5
Next Page »